ST.26 sequence listing

ST.26 Sequence listing Seamless Access to Sequence Data with Ease!

Every patent application that unveils nucleotide and/or amino acid sequences must adhere to international filing standards by including sequence listings. The imminent implementation of ST.26, a new sequence listing standard effective from July 1, 2022, is anticipated to enhance the structural framework for seamless data exchange and validation among patent offices and biological sequence search[…]

Understanding Sequence Listing in Patent Application and Scope of IP Protection

Understanding Sequence Listing in Patent Application and Scope of IP Protection

Biotechnology patent applications often involve nucleotide and amino acid sequences that require proper disclosure to obtain IP protection. The sequence listing is a standardized document essential at patent offices worldwide to provide a detailed description of these sequences. Moreover, patent applicants should ensure that their sequence listings comply with all applicable guidelines and requirements. This[…]